STOCK TITAN

Quest Diagnostics and The Commons Project to Deliver Convenient Access to Lab Data -- Including COVID-19 Test Results -- Through the CommonHealth App

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Very Positive)
Tags
covid-19
Rhea-AI Summary

Quest Diagnostics (NYSE: DGX) and The Commons Project announced a collaboration to enhance control over health data access, allowing individuals to view lab results and vaccination records through the CommonHealth app. The initiative aims to facilitate safer international travel and economic recovery by providing digital access to COVID-19 test results. With approximately 55% of U.S. residents using Android, this partnership positions Quest to leverage a significant user base for improving health decision-making.

Positive
  • Collaboration with The Commons Project enhances digital access to health data.
  • Facilitates easier access to COVID-19 test results and vaccination records.
  • Taps into 55% of U.S. Android users, increasing reach and user engagement.
Negative
  • None.

SECAUCUS, N.J., Dec. 17, 2020 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and The Commons Project, a non-profit public trust dedicated to building and operating global digital platforms and services for public good, today announced a collaboration that will give individuals more control over how and when they can access their data.

With the new collaboration, Quest Diagnostics also joins a handful of industry members of the Commons Project Foundation, which is focused on enabling people to access digital versions of their COVID-19 test results and vaccination records in order to more safely open international borders and resume economic activity.

Through the new collaboration, individuals can elect to access their Quest Diagnostics laboratory testing data through CommonHealth, the privacy-preserving Android app. The solution makes it easier for patients to access and review all their health data on a single, secure app.

"As patients navigate their health during the pandemic, and beyond, it is more important than ever to have their health data in one place," said Cathy Doherty, Senior Vice President and Group Executive, Clinical Franchise Solutions and Marketing for Quest Diagnostics. "By making Quest Diagnostics lab results accessible via CommonHealth, more individuals will have convenient access to their most critical and up-to-date health information, for better health decisions powered by diagnostic insights."

Approximately 55 percent of people in the United States are Android users. CommonHealth – available as a free download via Google Play – is the first and the only platform designed to allow users of the Android operating system to manage their medical records on Android-enabled devices and smartphones.

"As we expand our network with digital solutions that help people better manage their health, we need trusted members to help provide secure lab results and vaccination data in a timely and accurate way," said Dr. Brad Perkins, CMO, The Commons Project. "Our collaboration with Quest unlocks access to the world's largest database of clinical lab results for more than half the population that uses Android devices, putting them in control of their private health data."

CommonHealth aggregates health information, such as lab test results and vaccine information, from more than 320 U.S. hospitals and allows users to download, store, manage and share with other apps and services they trust. In doing so, Quest Diagnostics and The Commons Project intend to accelerate a shared vision to improve people's lives by giving them greater insight and control over their health data.

Quest's Commitment to Consumer Empowered Health
Quest Diagnostics has long been at the forefront of the movement for consumer empowerment in healthcare. The company was among the first diagnostic information services providers to offer free access to test results online and other channels. Its mobile app and patient portal, called MyQuest, provides its more than 14 million users a way to securely access and track their test results and other health data. The company's QuestDirect service provides dozens of tests for conditions ranging from heart health and sexually transmitted diseases. For added convenience, the company now offers at-home self-collection devices for tests including COVID-19 infection, diabetes, and hormones. Through its collaborations with Safeway and Walmart, Quest Diagnostics operates approximately 200 patient service centers in retail store locations, for the utmost in convenient access. Quest Diagnostics also provides next-generation sequencing and genotyping services for Ancestry.

About Quest Diagnostics
Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 47,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. www.QuestDiagnostics.com 

About The Commons Project
The Commons Project is a non-profit public trust building global digital services and platforms for the common good. Founded with support from the Rockefeller Foundation and based in Switzerland, it was established to build and operate the shared platforms and services that neither governments nor tech companies are well-positioned to create. The Commons Project's public trust governance structure is designed to ensure that people's interests are served above all. Learn more at thecommonsproject.org.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/quest-diagnostics-and-the-commons-project-to-deliver-convenient-access-to-lab-data----including-covid-19-test-results----through-the-commonhealth-app-301194550.html

SOURCE Quest Diagnostics

FAQ

What is the collaboration between Quest Diagnostics and The Commons Project about?

The collaboration focuses on enhancing individual access to lab results and vaccination records through the CommonHealth app.

How does the CommonHealth app benefit Android users?

The CommonHealth app provides Android users a secure way to access and manage their medical records, including lab results and vaccination data.

What percentage of U.S. residents are Android users benefiting from this initiative?

Approximately 55% of people in the United States are Android users, which the initiative targets.

When was the collaboration between Quest Diagnostics and The Commons Project announced?

The collaboration was announced on December 17, 2020.

What role does Quest Diagnostics play in the Commons Project?

Quest Diagnostics provides access to a comprehensive database of clinical lab results and vaccination data, enhancing the app's utility.

Quest Diagnostics Inc.

NYSE:DGX

DGX Rankings

DGX Latest News

DGX Stock Data

17.32B
111.62M
0.43%
91.4%
2.08%
Diagnostics & Research
Services-medical Laboratories
Link
United States of America
SECAUCUS